Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.

Exome sequencing reveals the likely involvement of SOX10 in uveal melanoma.

Das D, Kaur I, Ali MJ, Biswas NK, Das S, Kumar S, Honavar SG, Maitra A, Chakrabarti S, Majumder PP.

Optom Vis Sci. 2014 Jul;91(7):e185-92. doi: 10.1097/OPX.0000000000000309.

PMID:
24927141
2.

Chromosome 3 status combined with BAP1 and EIF1AX mutation profiles are associated with metastasis in uveal melanoma.

Ewens KG, Kanetsky PA, Richards-Yutz J, Purrazzella J, Shields CL, Ganguly T, Ganguly A.

Invest Ophthalmol Vis Sci. 2014 Jun 26;55(8):5160-7. doi: 10.1167/iovs.14-14550.

PMID:
24970262
3.

Genetic and clinico-pathologic analysis of metastatic uveal melanoma.

Griewank KG, van de Nes J, Schilling B, Moll I, Sucker A, Kakavand H, Haydu LE, Asher M, Zimmer L, Hillen U, Thompson JF, Scolyer RA, Schadendorf D, Murali R.

Mod Pathol. 2014 Feb;27(2):175-83. doi: 10.1038/modpathol.2013.138. Epub 2013 Jul 26.

4.

Mutation frequencies of GNAQ, GNA11, BAP1, SF3B1, EIF1AX and TERT in uveal melanoma: detection of an activating mutation in the TERT gene promoter in a single case of uveal melanoma.

Dono M, Angelini G, Cecconi M, Amaro A, Esposito AI, Mirisola V, Maric I, Lanza F, Nasciuti F, Viaggi S, Gualco M, Bandelloni R, Truini M, Coviello DA, Zupo S, Mosci C, Pfeffer U.

Br J Cancer. 2014 Feb 18;110(4):1058-65. doi: 10.1038/bjc.2013.804. Epub 2014 Jan 14.

5.

Comprehensive Genetic Landscape of Uveal Melanoma by Whole-Genome Sequencing.

Royer-Bertrand B, Torsello M, Rimoldi D, El Zaoui I, Cisarova K, Pescini-Gobert R, Raynaud F, Zografos L, Schalenbourg A, Speiser D, Nicolas M, Vallat L, Klein R, Leyvraz S, Ciriello G, Riggi N, Moulin AP, Rivolta C.

Am J Hum Genet. 2016 Nov 3;99(5):1190-1198. doi: 10.1016/j.ajhg.2016.09.008. Epub 2016 Oct 13.

6.

Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3.

Martin M, Maßhöfer L, Temming P, Rahmann S, Metz C, Bornfeld N, van de Nes J, Klein-Hitpass L, Hinnebusch AG, Horsthemke B, Lohmann DR, Zeschnigk M.

Nat Genet. 2013 Aug;45(8):933-6. doi: 10.1038/ng.2674. Epub 2013 Jun 23.

7.

Oncogenic GNAQ and GNA11 mutations in uveal melanoma in Chinese.

Xu X, Wei WB, Li B, Gao F, Zhang Z, Jonas JB.

PLoS One. 2014 Oct 3;9(10):e109699. doi: 10.1371/journal.pone.0109699. eCollection 2014.

8.

Metastatic disease in uveal melanoma: importance of a genetic profile?

Van Beek JG, Koopmans AE, Vaarwater J, Verdijk RM, de Klein A, Naus NC, Kiliç E.

Melanoma Res. 2015 Oct;25(5):447-9. doi: 10.1097/CMR.0000000000000176.

PMID:
26086698
9.

Uveal Melanomas with SF3B1 Mutations: A Distinct Subclass Associated with Late-Onset Metastases.

Yavuzyigitoglu S, Koopmans AE, Verdijk RM, Vaarwater J, Eussen B, van Bodegom A, Paridaens D, Kiliç E, de Klein A; Rotterdam Ocular Melanoma Study Group.

Ophthalmology. 2016 May;123(5):1118-28. doi: 10.1016/j.ophtha.2016.01.023. Epub 2016 Feb 26.

PMID:
26923342
10.

Lack of GNAQ germline mutations in uveal melanoma patients with high risk for hereditary cancer predisposition.

Abdel-Rahman MH, Pilarski R, Massengill JB, Christopher BB, Davidorf FH.

Fam Cancer. 2011 Jun;10(2):319-21. doi: 10.1007/s10689-010-9401-2.

PMID:
21072599
11.

Driver Mutations in Uveal Melanoma: Associations With Gene Expression Profile and Patient Outcomes.

Decatur CL, Ong E, Garg N, Anbunathan H, Bowcock AM, Field MG, Harbour JW.

JAMA Ophthalmol. 2016 Jul 1;134(7):728-33. doi: 10.1001/jamaophthalmol.2016.0903.

12.

SF3B1 mutations are associated with alternative splicing in uveal melanoma.

Furney SJ, Pedersen M, Gentien D, Dumont AG, Rapinat A, Desjardins L, Turajlic S, Piperno-Neumann S, de la Grange P, Roman-Roman S, Stern MH, Marais R.

Cancer Discov. 2013 Oct;3(10):1122-9. doi: 10.1158/2159-8290.CD-13-0330. Epub 2013 Jul 16.

13.

Lack of oncogenic GNAQ mutations in melanocytic lesions of the conjunctiva as compared to uveal melanoma.

Dratviman-Storobinsky O, Cohen Y, Frenkel S, Pe'er J, Goldenberg-Cohen N.

Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6180-2. doi: 10.1167/iovs.10-5677. Epub 2010 Jul 14.

PMID:
20631239
14.

Genetic landscape of uveal melanoma.

Rodrigues MJ, Stern MH.

J Fr Ophtalmol. 2015 Jun;38(6):522-5. doi: 10.1016/j.jfo.2015.04.004. Epub 2015 May 11.

15.

Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma.

Harbour JW, Roberson ED, Anbunathan H, Onken MD, Worley LA, Bowcock AM.

Nat Genet. 2013 Feb;45(2):133-5. doi: 10.1038/ng.2523. Epub 2013 Jan 13.

16.

Genomic, prognostic, and cell-signaling advances in uveal melanoma.

Harbour JW.

Am Soc Clin Oncol Educ Book. 2013:388-91. doi: 10.1200/EdBook_AM.2013.33.388. Review.

17.

Digital PCR validates 8q dosage as prognostic tool in uveal melanoma.

Versluis M, de Lange MJ, van Pelt SI, Ruivenkamp CA, Kroes WG, Cao J, Jager MJ, Luyten GP, van der Velden PA.

PLoS One. 2015 Mar 12;10(3):e0116371. doi: 10.1371/journal.pone.0116371. eCollection 2015.

18.

Recent developments in prognostic and predictive testing in uveal melanoma.

Field MG, Harbour JW.

Curr Opin Ophthalmol. 2014 May;25(3):234-9. doi: 10.1097/ICU.0000000000000051. Review.

19.

Immunohistochemical and molecular pathology of ocular uveal melanocytoma: evidence for somatic GNAQ mutations.

Mudhar HS, Doherty R, Salawu A, Sisley K, Rennie IG.

Br J Ophthalmol. 2013 Jul;97(7):924-8. doi: 10.1136/bjophthalmol-2013-303291. Epub 2013 May 17.

PMID:
23685997
20.

Distribution of GNAQ and GNA11 Mutation Signatures in Uveal Melanoma Points to a Light Dependent Mutation Mechanism.

de Lange MJ, Razzaq L, Versluis M, Verlinde S, Dogrusöz M, Böhringer S, Marinkovic M, Luyten GP, de Keizer RJ, de Gruijl FR, Jager MJ, van der Velden PA.

PLoS One. 2015 Sep 14;10(9):e0138002. doi: 10.1371/journal.pone.0138002. eCollection 2015.

Supplemental Content

Support Center